| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3e6845c7e625e6ff8191d13fdcb8e9e1 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55505 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-164 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-31 |
| filingDate |
2000-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b9772c033f18c9cc8b0272564e2cf5be
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dcc6306e794a1fcf19f4c6cb6ce85864
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d911e3f086f4c23be061af456e67b43 |
| publicationDate |
2005-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
NZ-528254-A |
| titleOfInvention |
Combined neisserial compositions |
| abstract |
A composition is disclosed which comprises an isolated first protein and an isolated second protein. The first protein is depicted to comprise an amino acid sequence which has 70% or more sequence identity to SEQ ID NO:894, 896 and/or 898 and/or is a fragment of 10 or more amino acids of SEQ ID NO:894, 896 and/or 898. The second protein is described to comprise an amino acid sequence selected from even-numbered SEQ ID NOs:2-4002, and/or is a fragment of 10 or more amino acids of even-numbered SEQ ID NOs:2-4002. There is a proviso that SEQ ID NOs:2182, 2184 and/or 2186 are not selectable sequences nor compose a fragment of the second protein. The use of the first and second proteins is disclosed to be in the manufacture of a medicament for treating or preventing infection due to the Neisserial bacteria. |
| priorityDate |
1999-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |